[肿瘤标志物在乳腺癌诊断和预后中的应用]
[Tumor markers in the diagnosis and prognosis of breast cancer].
作者信息
Seliuzhitskiĭ I V, Skvortsov S V, Lytsar B N, Khomenko L P
出版信息
Klin Med (Mosk). 1993;71(2):25-7.
PMID:8046917
Abstract
Serum levels of markers--mucinoid associated antigen (MAA), carcinoembryonal antigen (CEA) and carbohydrate antigen (CA-19-9) were measured in 78 breast cancer patients using enzyme immunoassay. It was found that MAA was most reliable of the above markers in staging breast cancer. A combined study of the latter is advisable in determination of breast cancer dissemination, in the control over the disease course and prognosis.
摘要
采用酶免疫分析法对78例乳腺癌患者的血清标志物——类黏蛋白相关抗原（MAA）、癌胚抗原（CEA）和糖类抗原（CA-19-9）水平进行了检测。结果发现，在乳腺癌分期中，MAA是上述标志物中最可靠的。在确定乳腺癌的播散情况、控制疾病进程及预后方面，建议对后者进行联合研究。
Zotero 插件